Analysts' Actions: AMTD, BA, FB, PCG, M

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

TD Ameritrade ( AMTD) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite.

Boeing ( BA) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $80 price target. Aerospace cycle remains strong.

Buckeye Technologies ( BKI) upgraded at UBS to Buy from Neutral, UBS said. $36 price target. Risks are higher, but sell off seems overdone.

Cummins ( CMI) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company is leveraged to a likely NAFTA truck inventory correction later this year.

Facebook ( FB) rated new Underperform at Bernstein. $25 price target. Company will likely struggle to achieve sales growth targets.

Huntington Bancshares ( HBAN) downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. $6 price target. Company is leveraged to lower interest rates.

HealthSouth ( HLS) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call.

KAR Auction ( KAR) upgraded at Baird to Outperform, Robert Baird said. Valuation call, based on a $21 price target.

NY Community Bancorp ( NYB) downgraded at FBR. NYB was downgraded from Outperform to Market Perform, FBR Capital Markets said. $13.50 price target. Estimates also cut, given lower expected net interest margin.

PG&E ( PCG) rated new Equal-weight at Morgan Stanley. $47 price target. Risk/reward is neutral at cuirrent levels.

Pioneer Natural ( PXD) upgraded at Societe Generale from Sell to Hold, Societe Generale said. Valuation call, based on a $92 price target.

Regions Financial ( RF) downgraded at Morgan Stanley from Buy to Hold, Morgan Stanley said. $6.50 price target. Company is leveraged to slower macro growth and lower interest rates.

Charles Schwab ( SCHW) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite.

Zions Bancorporation ( ZION) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $21 price target. Company needs to cut costs, to cope with the lower interest rate environment.

STOCK COMMENTS / EPS CHANGES

Express Scripts ( ESRX) numbers lowered at BMO through 2013, BMO Capital said. Company is facing higher debt costs, following the Medco merger. Market Perform rating and new $50 price target.

Itron ( ITRI) estimates, target cut at JP Morgan. Shares of ITRI now seen reaching $48, according to JP Morgan. Estimates also reduced, given higher macro uncertainty. Overweight rating.

Macy's ( M) removed from Top Picks Live! at Citigroup. Strong outperformance and SSS comps are challenging. Maintain $49 price target and Buy rating.

Manpower ( MAN) estimates, target cut at BofA/Merrill. Shares of MAN now seen reaching $40. Estimates also reduced, given slower European activity. Neutral rating.

Mattel ( MAT) estimates reduced at Wells through 2013, Wells Fargo said. Company is leveraged to a stronger dollar. Outperform rating.

Medivation ( MDVN) target raised at Jefferies. Shares of MDVN now seen reaching $105. Zytiga pre-chemo survival data bode well for Enzalutamide's prospect. Buy rating.

Medivation estimates, target raised at Credit Suisse. Shares of MDVN now seen reaching $122, according to Deutsche Bank. Estimates also increased, as new pre-chemo data looks impressive. Outperform rating.

Monsanto ( MON) estimates, target boosted at BofA/Merrill. Shares of MON now seen reaching $96, according to Bank of America/Merrill Lynch. Company should see higher domestic corn and soybean demand. Buy rating.

OGE Energy ( OGE) numbers raised at Jefferies. Shares of OGE now seen reaching $57, Jefferies said. Estimates also raised on interim rate increase. Hold rating.

Skyworks ( SWKS) estimates upped at JMP through 2013, JMP Securities said. Channel checks suggest higher growth. Outperform rating and $40 price target.

Trimble ( TRMB) estimates, target cut at JP Morgan. Shares of TRMB now seen reaching $55, according to JP Morgan. Estimates also reduced, given macro uncertainty. Overweight rating.

Wal-Mart ( WMT) estimates increased at Morgan Stanley through 2015, Morgan Stanley said. Company has solid operating leverage. Equal-weight rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.